Hematopoietic niches, erythropoiesis and anemia of chronic infection

Experimental Hematology

Volumn 44, Issue 2, 2016, Pages 85-91

  Gomes, Ana Cordeiro ^a   Gomes, Maria Salomé ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN RECEPTOR; GAMMA INTERFERON; HEME OXYGENASE 1; HEPCIDIN; IRON; TOLL LIKE RECEPTOR;

ANEMIA; BONE MARROW; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL PROLIFERATION; CELL STRESS; CELLULAR STRESS RESPONSE; COLONY FORMING UNIT; CYTOKINE PRODUCTION; ERYTHROBLAST; ERYTHROID CELL; ERYTHROPOIESIS; HEMATOPOIETIC CELL; HOMEOSTASIS; HUMAN; INFECTION; MYCOBACTERIOSIS; MYELOPOIESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STEM CELL NICHE; ANIMAL; CHRONIC DISEASE; HEMATOPOIESIS; METABOLISM;

ANEMIA; ANIMALS; CHRONIC DISEASE; ERYTHROPOIESIS; HEMATOPOIESIS; HOMEOSTASIS; HUMANS; IRON;

EID: 84957551036     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2015.11.007     Document Type: Review

References (84)

1. Schofield R. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 1978, 4:7-25.
2. Ding L., Morrison S.J. Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches. Nature 2013, 495:231-235.
3. Ding L., Saunders T.L., Enikolopov G., Morrison S.J. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 2012, 481:457-462.
4. Bruns I., Lucas D., Pinho S., et al. Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 secretion. Nat Med 2014, 20:1315-1320.
5. Kunisaki Y., Bruns I., Scheiermann C., et al. Arteriolar niches maintain haematopoietic stem cell quiescence. Nature 2013, 502:637-643.
6. Greenbaum A., Hsu Y.M., Day R.B., et al. CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance. Nature 2013, 495:227-230.
7. Sugiyama T., Kohara H., Noda M., Nagasawa T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 2006, 25:977-988.
8. Nie Y., Han Y.C., Zou Y.R. CXCR4 is required for the quiescence of primitive hematopoietic cells. J Exp Med 2008, 205:777-783.
9. Frenette P.S., Pinho S., Lucas D., Scheiermann C. Mesenchymal stem cell: Keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine. Annu Rev Immunol 2013, 31:285-316.
10. Mendez-Ferrer S., Michurina T.V., Ferraro F., et al. Mesenchymal and hematopoietic stem cells form a unique bone marrow niche. Nature 2010, 466:829-834.
11. Pinho S., Lacombe J., Hanoun M., et al. PDGFRalpha and CD51 mark human nestin+ sphere-forming mesenchymal stem cells capable of hematopoietic progenitor cell expansion. J Exp Med 2013, 210:1351-1367.
12. Morrison S.J., Hemmati H.D., Wandycz A.M., Weissman I.L. The purification and characterization of fetal liver hematopoietic stem cells. Proc Natl Acad Sci U S A 1995, 92:10302-10306.
13. Zhou B.O., Yue R., Murphy M.M., Peyer J.G., Morrison S.J. Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow. Cell Stem Cell 2014, 15:154-168.
14. Nagasawa T., Satoh K., Abe T. Thrombopoietic factor enhances murine megakaryopoiesis induced by recombinant erythropoietin. Int J Hematol 1991, 54:159-164.
15. Omatsu Y., Sugiyama T., Kohara H., et al. The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche. Immunity 2010, 33:387-399.
16. Omatsu Y., Seike M., Sugiyama T., Kume T., Nagasawa T. Foxc1 is a critical regulator of haematopoietic stem/progenitor cell niche formation. Nature 2014, 508:536-540.
17. Li W., Johnson S.A., Shelley W.C., et al. Primary endothelial cells isolated from the yolk sac and para-aortic splanchnopleura support the expansion of adult marrow stem cells in vitro. Blood 2003, 102:4345-4353.
18. Lu L.S., Wang S.J., Auerbach R. In vitro and in vivo differentiation into B cells, T cells, and myeloid cells of primitive yolk sac hematopoietic precursor cells expanded >100-fold by coculture with a clonal yolk sac endothelial cell line. Proc Natl Acad Sci U S A 1996, 93:14782-14787.
19. Rafii S., Shapiro F., Pettengell R., et al. Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors. Blood 1995, 86:3353-3363.
20. Ohneda O., Fennie C., Zheng Z., et al. Hematopoietic stem cell maintenance and differentiation are supported by embryonic aorta-gonad-mesonephros region-derived endothelium. Blood 1998, 92:908-919.
21. Yao L., Yokota T., Xia L., Kincade P.W., McEver R.P. Bone marrow dysfunction in mice lacking the cytokine receptor gp130 in endothelial cells. Blood 2005, 106:4093-4101.
22. Calvi L.M., Adams G.B., Weibrecht K.W., et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003, 425:841-846.
23. Zhang J., Niu C., Ye L., et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003, 425:836-841.
24. Visnjic D., Kalajzic Z., Rowe D.W., Katavic V., Lorenzo J., Aquila H.L. Hematopoiesis is severely altered in mice with an induced osteoblast deficiency. Blood 2004, 103:3258-3264.
25. Arai F., Hirao A., Ohmura M., et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 2004, 118:149-161.
26. Wilson A., Murphy M.J., Oskarsson T., et al. c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev 2004, 18:2747-2763.
27. Taichman R.S., Reilly M.J., Emerson S.G. Human osteoblasts support human hematopoietic progenitor cells in vitro bone marrow cultures. Blood 1996, 87:518-524.
28. Taichman R.S. Blood and bone: Two tissues whose fates are intertwined to create the hematopoietic stem-cell niche. Blood 2005, 105:2631-2639.
29. Zhu J., Garrett R., Jung Y., et al. Osteoblasts support B-lymphocyte commitment and differentiation from hematopoietic stem cells. Blood 2007, 109:3706-3712.
30. Chow A., Lucas D., Hidalgo A., et al. Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. J Exp Med 2011, 208:261-271.
31. Schurch C.M., Riether C., Ochsenbein A.F. Cytotoxic CD8(+) T cells stimulate hematopoietic progenitors by promoting cytokine release from bone marrow mesenchymal stromal cells. Cell Stem Cell 2014, 14:460-472.
32. Nakada D., Oguro H., Levi B.P., et al. Oestrogen increases haematopoietic stem-cell self-renewal in females and during pregnancy. Nature 2014, 505:555-558.
33. Mendez-Ferrer S., Lucas D., Battista M., Frenette P.S. Haematopoietic stem cell release is regulated by circadian oscillations. Nature 2008, 452:442-447.
34. Mendez-Ferrer S., Battista M., Frenette P.S. Cooperation of beta(2)- and beta(3)-adrenergic receptors in hematopoietic progenitor cell mobilization. Ann NY Acad Sci 2010, 1192:139-144.
35. Back J., Dierich A., Bronn C., Kastner P., Chan S. PU.1 determines the self-renewal capacity of erythroid progenitor cells. Blood 2004, 103:3615-3623.
36. Kapur R., Cooper R., Zhang L., Williams D.A. Cross-talk between alpha(4)beta(1)/alpha(5)beta(1) and c-Kit results in opposing effect on growth and survival of hematopoietic cells via the activation of focal adhesion kinase, mitogen-activated protein kinase, and Akt signaling pathways. Blood 2001, 97:1975-1981.
37. Grover A., Mancini E., Moore S., et al. Erythropoietin guides multipotent hematopoietic progenitor cells toward an erythroid fate. J Exp Med 2014, 211:181-188.
38. Von Lindern M., Schmidt U., Beug H. Control of erythropoiesis by erythropoietin and stem cell factor: A novel role for Bruton's tyrosine kinase. Cell Cycle 2004, 3:876-879.
39. Skutelsky E., Danon D. On the expulsion of the erythroid nucleus and its phagocytosis. Anat Rec 1972, 173:123-126.
40. Soni S., Bala S., Gwynn B., Sahr K.E., Peters L.L., Hanspal M. Absence of erythroblast macrophage protein (Emp) leads to failure of erythroblast nuclear extrusion. J Biol Chem 2006, 281:20181-20189.
41. Chow A., Huggins M., Ahmed H.M., et al. CD169(+) macrophages provide a niche promoting erythropoiesis under homeostasis and stress. Nat Med 2013, 19:429-436.
42. Leimberg M.J., Prus E., Konijn A.M., Fibach E. Macrophages function as a ferritin iron source for cultured human erythroid precursors. J Cell Biochem 2008, 103:1211-1218.
43. Jacobsen R.N., Forristal C.E., Raggatt L.J., et al. Mobilization with granulocyte colony-stimulating factor blocks medullar erythropoiesis by depleting F4/80(+)VCAM1(+)CD169(+)ER-HR3(+)Ly6G(+) erythroid island macrophages in the mouse. Exp Hematol 2014, 42:547-561.
44. Christopher M.J., Rao M., Liu F., Woloszynek J.R., Link D.C. Expression of the G-CSF receptor in monocytic cells is sufficient to mediate hematopoietic progenitor mobilization by G-CSF in mice. J Exp Med 2011, 208:251-260.
45. Winkler I.G., Sims N.A., Pettit A.R., et al. Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. Blood 2010, 116:4815-4828.
46. Kautz L., Jung G., Valore E.V., Rivella S., Nemeth E., Ganz T. Identification of erythroferrone as an erythroid regulator of iron metabolism. Nat Genet 2014, 46:678-684.
47. Donovan A., Lima C.A., Pinkus J.L., et al. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab 2005, 1:191-200.
48. De Domenico I., Ward D.M., Kaplan J. Hepcidin regulation: Ironing out the details. J Clin Invest 2007, 117:1755-1758.
49. Goodnough L.T., Nemeth E., Ganz T. Detection, evaluation, and management of iron-restricted erythropoiesis. Blood 2010, 116:4754-4761.
50. Kim A., Fung E., Parikh S.G., et al. A mouse model of anemia of inflammation: complex pathogenesis with partial dependence on hepcidin. Blood 2014, 123:1129-1136.
51. Gardenghi S., Renaud T.M., Meloni A., et al. Distinct roles for hepcidin and interleukin-6 in the recovery from anemia in mice injected with heat-killed Brucella abortus. Blood 2014, 123:1137-1145.
52. Nicolas G., Chauvet C., Viatte L., et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 2002, 110:1037-1044.
53. Nemeth E., Ganz T. Anemia of inflammation. Hematol Oncol Clin North Am 2014, 28:671-681.
54. Ganz T., Nemeth E. Iron homeostasis in host defence and inflammation. Nat Rev Immunol 2015, 15:500-510.
55. Bullock G.C., Delehanty L.L., Talbot A.L., et al. Iron control of erythroid development by a novel aconitase-associated regulatory pathway. Blood 2010, 116:97-108.
56. Richardson C.L., Delehanty L.L., Bullock G.C., et al. Isocitrate ameliorates anemia by suppressing the erythroid iron restriction response. J Clin Invest 2013, 123:3614-3623.
57. Rodrigues P.N., Gomes S.S., Neves J.V., et al. Mycobacteria-induced anaemia revisited: A molecular approach reveals the involvement of NRAMP1 and lipocalin-2, but not of hepcidin. Immunobiology 2011, 216:1127-1134.
58. Johnson R.A., Waddelow T.A., Caro J., Oliff A., Roodman G.D. Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice. Blood 1989, 74:130-138.
59. Libregts S.F., Gutiérrez L., de Bruin A.M., et al. Chronic IFN-γ production in mice induces anemia by reducing erythrocyte life span and inhibiting erythropoiesis through an IRF-1/PU.1 axis. Blood 2011, 118:2578-2588.
60. Felli N., Pedini F., Zeuner A., et al. Multiple members of the TNF superfamily contribute to IFN-gamma-mediated inhibition of erythropoiesis. J Immunol 2005, 175:1464-1472.
61. Baldridge M.T., King K.Y., Boles N.C., Weksberg D.C., Goodell M.A. Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection. Nature 2010, 465:793-797.
62. Essers M.A., Offner S., Blanco-Bose W.E., et al. IFNalpha activates dormant haematopoietic stem cells in vivo. Nature 2009, 458:904-908.
63. Pevsner-Fischer M., Morad V., Cohen-Sfady M., et al. Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 2007, 109:1422-1432.
64. Liotta F., Angeli R., Cosmi L., et al. Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling. Stem Cells 2007, 26:279-289.
65. Hwa Cho H., Bae Y.C., Jung J.S. Role of toll-like receptors on human adipose-derived stromal cells. Stem Cells 2006, 24:2744-2752.
66. Tomchuck S.L., Zwezdaryk K.J., Coffelt S.B., Waterman R.S., Danka E.S., Scandurro A.B. Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses. Stem Cells 2008, 26:99-107.
67. Shi C., Kia T., Mendez-Ferrer S., et al. Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating toll-like receptor ligands. Immunity 2011, 34:590-601.
68. Duque G., Huang D.C., Macoritto M., et al. Autocrine regulation of interferon gamma in mesenchymal stem cells plays a role in early osteoblastogenesis. Stem Cells 2009, 27:550-558.
69. Hardy R., Cooper M.S. Bone loss in inflammatory disorders. J Endocrinol 2009, 201:309-320.
70. Mohanty S.T., Kottam L., Gambardella A., et al. Alterations in the self-renewal and differentiation ability of bone marrow mesenchymal stem cells in a mouse model of rheumatoid arthritis. Arthritis Res Ther 2010, 12:R149.
71. Dazzi F., Krampera M. Mesenchymal stem cells and autoimmune diseases. Best Pract Res Clin Haematol 2011, 24:49-57.
72. Ghannam S., Pene J., Moquet-Torcy G., Jorgensen C., Yssel H. Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype. J Immunol 2010, 185:302-312.
73. Prigione I., Benvenuto F., Bocca P., Battistini L., Uccelli A., Pistoia V. Reciprocal interactions between human mesenchymal stem cells and gammadelta T cells or invariant natural killer T cells. Stem Cells 2009, 27:693-702.
74. Chabannes D., Hill M., Merieau E., et al. A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells. Blood 2007, 110:3691-3694.
75. Mougiakakos D., Jitschin R., Hohansson C.C., Okita R., Kiessling R., Le Blanc K. The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells. Blood 2011, 117:4826-4835.
76. Aggarwal S., Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005, 105:1815-1822.
77. Fraser S.T., Midwinter R.G., Coupland L.A., et al. Heme oxygenase-1 deficiency alters erythroblastic island formation, steady-state erythropoiesis and red blood cell lifespan in mice. Haematologica 2015, 100:601-610.
78. Silva-Gomes S., Appelberg R., Larsen R., Soares M.P., Gomes M.S. Heme catabolism by heme oxygenase-1 confers host resistance to Mycobacterium infection. Infect Immun 2013, 81:2536-2545.
79. Xiao W., Koizumi K., Nishio M., Endo T., Osawa M., Fujimoto K. Tumor necrosis factor-alpha inhibits generation of glycophorin A+ cells by CD34+ cells. Exp Hematol 2002, 30:1238-1247.
80. Naveiras O., Nardi V., Wenzel P.L., Hauschka P.V., Fahey F., Daley G.Q. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature 2009, 460:259-263.
81. Finch C. Regulators of iron balance in humans. Blood 1994, 84:1697-1702.
82. Li H., Ghazanfari R., Zacharaki D., et al. Low/negative expression of PDGFR-alpha identifies the candidate primary mesenchymal stromal cells in adult human bone marrow. Stem Cell Reports 2014, 3:965-974.
83. Isern J., Martin-Antonia B., Ghazanfari R., et al. Self-renewing human bone marrow mesenspheres promote hematopoietic stem cell expansion. Cell Rep 2013, 3:1714-1724.
84. Ferraro F., Lympen S., Mendez-Ferrer S., et al. Diabetes impairs hematopoietic stem cell mobilization by altering niche function. Sci Transl Med 2011, 3:104ra101.